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The effect of glucose on the release of immunoreactive insulin (IRI) in synaptosomes isolated from
rat brain was studied. In the absence of glucose synaptosomes release about 4% (0.77 |UiU/mg
protein) of total content. Glucose increases significantly the IRI released by synaptosomes. Addition
of the glycolytic inhibitor iodoacetic acid (IAA), decreased the glucose-induced release of IRI by
about 50%, suggesting that glucose metabolism is involved. The observation that glucose provides
a concentration related signal for IRI release indicates that this synaptosomal preparation may be
useful as a model for research on the mechanism of insulin release in brain.
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INTRODUCTION
Under normal physiological conditions, glucose is
the most important source of energy utilized by brain.
Besides yielding ATP, glucose metabolism contributes
to the synthesis of the neurotransmitters acetylcholine,
glutamate, aspartate, GABA and glycine. Perturbations
in the supply of glucose, as well as impairments of glu-
cose metabolism, modify brain function (1). The glucose
transport from blood into the brain is mediated by at
least two glucose transporter proteins, GLUT1 and
GLUT3 (2). It was proposed that up regulation of ex-
pression of GLUT3, which is present predominantly in
neurons, under glucose deprivation or ischaemic insult,
represents a protective mechanism against energy deple-
tion in neurons (3-6).
Presently, there is a great deal of evidence that gly-
colytic flux and oxidative metabolism in brain are stim-
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ulated by insulin indicating that the control of glucose
metabolism by insulin is similar to that observed in non-
neuronal tissues (7-9). On the other hand, the existence
of both insulin and insulin receptors in brain is well es-
tablished (10,11). Most of brain insulin is assumed to be
transported from the periphery, but at present there is
increasing evidence that insulin or insulin-like peptide
can also be synthesized by neurons in high localized
areas of the brain (12).
The presence of insulin, insulin receptors and glu-
cose transporters in brain makes it likely that neurons
may respond to glucose concentration by releasing in-
sulin. Since synaptosomes isolated from rat brain store
IRI in synaptic vesicles, from which it can be released
by exocytosis (13), we studied and reported here the
release of IRI in response to glucose.
EXPERIMENTAL PROCEDURE
Preparation of Synaptosomes. Crude synaptosomes were pre-
pared from brain of male Wistar rats (180-220 g), according to the
method of Hajos (24), with some modifications. In brief, the whole
brain was homogenized in 10 volumes of 0.32 M sucrose buffered at
pH 7.4 with Tris. The homogenate was centrifuged at 1,000 g for 10
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Fig. 1. Effect of glucose on the release of immunoreactive insulin (IRI)
in synaptosomes. Synaptosomes were incubated for 10 min at 30 °C
as described in Experimental Procedure. IRI data, expressed as a per-
centage of basal release observed in the absence of glucose, are mean
± SEM from 12 experiments except the DG experiments which are
n = 5. *p < 0.05, **p < 0.001, as compared with the release in the
absence of glucose; Tp < 0.01, TTp < 0.001, as compared with the
release in the presence of DG in glucose-free medium. IRI release in
0 mM glucose was 0.77 ± 0.17 UIU/mg protein/10 min.
min and the synaptosomes were isolated from the supernatant by cen-
trifugation at 12,000 g for 20 min. The white and fluffy synaptosome
layer was then resuspended, respun and resuspended in the sucrose
medium at a protein concentration of 15-20 mg/ml, as determined by
the biuret method. Experiments were carried out within 2 h of prep-
aration.
Incubation Conditions. Synaptosomes were incubated at a con-
centration of 3-4 mg protein/ml, for 10 min at 30 °C in a standard
medium containing (in mM): 118 NaCl, 3 KC1, 1.2 MgCl2, 1 NaH2PO4,
1.2 CaCl2, 10 Hepes adjusted to pH 7.4 with Tris, 0.1% of bovine
serum albumin and various concentrations of glucose. The incubation
was terminated by centrifugation (120 s in a Eppendorf microcentri-
fuge), and the supernatant was radioimmunoassayed for IRI. The total
radioimmunoactive insulin in synaptosomes was measured according
to the method described by Tesoriere et al. (25). The synaptosomes
were lysed with water (1 ml/3-4 mg protein) and sonicated for 30 sec
(3 pulses of 10 sec). The homogenates were centrifuged at 20,000 g
for 10 min and the supernatants assayed. IRI extracts from whole rat
brain were prepared by the method of Havrankova et al. (14).
Conditions of low metabolism were induced in synaptosomes in-
cubated in the presence of chemical agents, as previously described
(17): (1) 2 mM KCN + 5 Ug/ml oligomycin (2) 2 mM IAA and (3)
2 mM DG. KCN inhibits the respiratory chain by inhibiting cyto-
chrome c oxidase, oligomycin inhibits the ATP synthase, IAA, which
inhibits the glycolytic enzyme glyceraldehyde dehydrogenase and DG
which substitutes glucose in the medium and is not metabolized by
the cells inhibiting competitively glycolysis and glycogenolysis. Test
compounds were introduced into the incubation medium before the
addition of protein. In experiments where glucose was omitted, NaCl
was raised to 123 mM.
Measurement of Immunoreactive Insulin (IRI) in Brain and Syn-
aptosomes. Immunoreactive insulin was measured by using the Coat-
A-Count radioimmunoassay insulin assay kit (Diagnostic Products
Corporation, Los Angeles CA, USA).
Statistics. Statistical analysis of data was carried out by using the
one-factor ANOVA with a Fisher's PLSD post-test for multiple com-
parisons. The means ± SEM are presented and differences with a P
value < 0.05 were considered significant.
RESULTS
Data presented in Fig. 1 show that glucose in-
creased the release of IRI in rat brain synatosomes. The
presence of 17 mM of glucose also elicited IRI release
but the amount of IRI released did not differ signifi-
cantly from that seen with 3 or 10 mM glucose. The
released IRI at 0 mM glucose in the medium (0.77 ±
0.17 UUI/mg protein represented about 4% of the total
synaptosomal IRI content (21.82 ± 3.67 UUI/mg pro-
tein, Table I). In comparison with whole brain extracts,
which contains 5.68 ± 0.32 UUI/mg protein (134.9 ±
18.2 UUI/g wet brain), synaptosomes were enriched
about 4 fold (Table I).
To determine whether glucose-induced IRI release
was related to glycolysis, we tested the effect of IAA
and DG, two known inhibitors of glycolysis. As shown
in Fig. 1, DG significantly reduced the release of IRI by
about 30% in synaptosomes incubated in the absence of
glucose. Table II shows the release of IRI from synap-
tosomes incubated in the presence of 17 mM glucose.
The addition of 2 mM of IAA into the assay medium
caused a significant decrease (p < 0.05), in the IRI level
as compared to control synaptosomes. The amount of
IRI release under hypoxic-like conditions, when oxida-
tive metabolism is inhibited by KCN + olygomycin,
was increased by about 35% when compared with the
IRI released in control conditions (Table II).
Table I. Immunoreactive Insulin (IRI) Content in Brain and
Synaptosomal Preparations
Whole rat brain
Synaptosomal preparation
IRI content
5.68 ± 0.32 UUI/mg protein
(n = 5)
21.82 ± 3.67 UUI/mg protein
(n= 11)
IRI content was determined by the radioimmunoassay technic. Con-
ditions of analysis are described in Experimental Procedure. Results
are the mean ± SEM for the number (n) of experiments indicated.
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DISCUSSION
The results reported in this paper show that IRI is
present in rat brain synaptosomes and that glucose
causes an enhancement of the IRI release. The level of
whole rat brain IRI determined in our study is well in
accord with the values reported by various laboratories
(10,13,14). If 1 g insulin contains 25 IU of bioactivity,
the total whole brain extract contains about 5 ng IRI per
g wet brain. This value is near the mean values previ-
ously reported (3-9 ng/g, 10, 13). However, the content
in IRI of our synaptosomal preparation (0.873 ng/mg
protein), is fivefold higher than that observed by others
in purified synaptosomes (0.185 ng/mg protein) (13).
These differences are probably due to different isolation
methods and/or to different extraction procedures.
In pancreatic B-cells the rate of glucose metabolism
is the major determinant of insulin secretion (15). We
found that the release of IRI was significantly enhanced
when synaptosomes were exposed to increasing concen-
trations of glucose (Fig. 1), suggesting that the release
of IRI in brain is regulated by glucose metabolism.
When DG or IAA was added to the reaction medium
the IRI release was inhibited. This finding shows that
the effect of glucose in IRI is exerted through glycolysis.
Additionally, insulin release from rat brain neuronal
cells in culture and synaptosomal preparations was also
observed following depolarization with veratridine or K+
in the presence of Ca2+ (13,16), suggesting that other
mechanism(s) are involved in the IRI release in brain.
The lower release produced by DG or IAA than by
glucose deprivation is probably explained by the pres-
ence of endogenous substrates that can sustain glycolysis
in the absence of glucose. Inhibition with glycolytic in-
hibitors produces a complete glycolytic blockade (17).
Glycolysis plays a very important role in regulating en-
ergy status in nerve terminals (18). The increase in IRI
observed in synaptosomes under anoxia-like conditions
suggests that under anoxia glycolysis may be stimulated.
The stimulation of glycolysis was already proposed to
occur in synaptosomes, upon inhibition of the respiratory
chain by cyanide (18).
Thus glucose metabolism may provide a signal for
insulin release in the brain. Interestingly, a beneficial
effect of insulin in reducing cerebral brain damage dur-
ing several stress conditions, such as ischaemia and trau-
matic brain injury was recently demonstrated, suggesting
that insulin could be neuroprotective per si (19-21). De-
sensitization of the neuronal insulin receptors and dis-
turbances in glucose metabolism are hypothesized to be
a cause of the age-associated neurodegenerative disor-
ders like in Alzheimer and Parkinson's disease (22,23).
At present the exact mechanism by which glucose leads
to increase in IRI in brain is not known. In this regard,
we are investigating the involvement of K+ATP chan-
nels, plasma membrane potential, Ca2+ influx and
changes in ATP or ATP/ADP ratio on the glucose-in-
duced IRI release.
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